Welch Stephen Andrew 4
4 · Keenova Therapeutics plc · Filed Nov 12, 2025
Insider Transaction Report
Form 4
Welch Stephen Andrew
EVP & Head of Spec Generics
Transactions
- Disposition to Issuer
Restricted Stock Units
2025-11-10+43,771→ 0 total→ Ordinary Shares (43,771 underlying)
Footnotes (1)
- [F1]These restricted units were cancelled in connection with the separation of Par Health, Inc. ("Par Health") from the Issuer in exchange for a number of restricted units of Par Health calculated pursuant to the terms of the Employee Matters Agreement by and between the Issuer and Par Health.